Experience of Lung Surgery in the COVID-19 Pandemic

Kubilay İnan; İlknur Aytekin Çelik; Nurettin Karaoğlanoğlu

doi:10.58600/eurjther-342

Authors

Kubilay İnan Ankara Bilkent City Hospital, Department of Thoracic Surgery https://orcid.org/0000-0002-1409-4760
İlknur Aytekin Çelik Yıldırım Beyazıt University, Faculty of Medicine, Ankara Bilkent City Hospital, Department of Thoracic Surgery https://orcid.org/0000-0003-0754-680X
Nurettin Karaoğlanoğlu Yıldırım Beyazıt University, Faculty of Medicine, Ankara Bilkent City Hospital, Department of Thoracic Surgery https://orcid.org/0000-0003-2827-6044

DOI:

https://doi.org/10.58600/eurjther-342

Keywords:

Lung cancer, covid-19, thoracic surgery

Abstract

Objective: During the pandemic, elective cases other than those requiring emergency thoracic surgery were postponed. Depending on the magnitude of the impact the pandemic posed on hospitals and clinics, there have been changes in the number and variety of cases of thoracic surgery. The intention behind conducting this study was to share the experiences gained by a thoracic surgery clinic during the pandemic period.
Methods: Altogether, 214 patients were included in the study. Patient data that were recorded included those on age, gender, lung pathology, duration of hospital stay, positivity for COVID-19, survival, and causes of death.
Results: Of the 214 patients operated on, 12 died during the postoperative period. Eight of these patients died due to their primary disease and one died due to gastrointestinal bleeding, whereas the remaining three patients died due to COVID-19 infection.
Conclusions: If opportunities and facilities favorable for the administration of surgical treatment are made available, surgical treatment services can be offered safely to all patients

Metrics

Metrics Loading ...

References

Thoracic Surgery Outcomes Research Network, Inc, Antonoff M, Backhus L, Boffa DJ, Broderick SR, Brown LM, Carrott P et al. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. J Thorac Cardiovasc Surg. 2020;160(2):601-605.

National Comprehensive Cancer Network (NCCN) Short-Term Recommendations for Non–small Cell Lung Cancer Management During the COVID-19 Pandemic. Last Accessed Date: 15.06.2017. Available from: https://www.nccn.org/covid-19/pdf/COVID_NSCLC.pdf

American College of Surgeons COVID 19: Elective Case Triage Guidelines for Surgical Care: Thoracic Cancer Surgery. Last Accessed Date: 15.06.2017. Available from: https://www.facs.org/-/media/files/covid19/guidance_for_triage_of_nonemergent_surgical_procedures_thoracic_cancer.ashx

Vansteenkiste J, De Ruysscher D, Eberhardt WE et al. ESMO Guidelines Working Group. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi89-vi98.

National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Non–small Cell Lung Cancer (Version 3.2020). Last Accessed Date: 15.06.2017. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx

Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC et al. Management of lung nodules and lung cancer screening during the COVID-19 pandemic: CHEST Expert Panel Report. Chest. 2020;158(1):406-415.

Singh AP, Berman AT, Marmarelis ME, Haas AR, Feigenberg SJ, Braun J et al. Management of lung cancer during the COVID-19 pandemic. JCO Oncol Pract. 2020;16(9):579-586.

Passaro A, Addeo A, Von Garnier C, Blackhall F, Planchard D, Felip E et al. ESMO management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open. 2020;5:e000820.

Hassan M, Le UT, Grapatsas K, Passlick B, Schmid S. Onkologische Thoraxchirurgie während der COVID-19-Pandemie: eine Fallkontrollstudie zum Risiko für postoperative Komplikationen [Surgery for Thoracic Malignancies during the COVID-19 Pandemic: a Case-control Study Investigating the Risk for Postoperative Complications]. Zentralbl Chir. 2021;146(6):579-585.

Seitlinger J, Wollbrett C, Mazzella A, Schmid S, Guerrera F, Banga Nkomo D et al. Safety and feasibility of thoracic malignancy surgery during the COVID-19 pandemic. Ann Thorac Surg. 2021;112(6):1870-1876.

Stoleriu MG, Gerckens M, Ströh K, Kovács J, Samm N, Obereisenbuchner F et al. Prevention of COVID-19 in thoracic surgery patients: lessons learned during the first pandemic wave. Pneumologie. 2021;75(12):960-970.

Agrawal MB, Awad NT. Correlation between six minute walk test and spirometry in chronic pulmonary disease. J Clin Diagn Res. 2015;9(8):OC01-4.

Fujimoto H, Asai K, Watanabe T, Kanazawa H, Hirata K. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD). Osaka City Med J. 2011;57(1):21-29.

Yang CJ. Commentary: Thoracic surgery during the COVID-19 pandemic: Recommendations from China. J Thorac Cardiovasc Surg. 2020;160(4):e233-e235.

Maurizi G, Rendina EA. A high-volume thoracic surgery division into the storm of the COVID-19 pandemic. Ann Thorac Surg. 2020;110(2):353-354.